Clinicians began exploring this approach for a few reasons: Not everyone needs aggressive appetite suppression to improve metabolic health Some people are more sensitive to GLP-1 medications Side effects often increase with higher doses Cost and long-term sustainability matter Women, in particular, started asking different questions
People with kidney disease, a seizure disorder, thyroid concerns, or who are pregnant or breastfeeding should not use L-carnitine without specific medical clearance
2ml weekly is at the high end of standard protocols and appropriate for loading phases, concurrent GLP-1 therapy, or documented hepatic steatosis
While the timing of most injections relative to meals does not affect drug absorption, strategic meal planning can help manage gastrointestinal symptoms
It may help you lose more weight than other drugs on the market
Sources: Aguirre GA, De Ita JR, de la Garza RG, Castilla-Cortazar I